Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
American Journal of Physiology. Cell Physiology
|
May 15, 2023
Combined application of biosponges and an antifibrotic agent for the treatment of volumetric muscle loss
Charles West, Connor Tobo, Jeffrey Au, et al.
Biochemical and Biophysical Research Communications
|
September 23, 2006
VCC-1, a novel chemokine, promotes tumor growth
Edward J Weinstein, Richard Head, David W Griggs, et al.
Analytical Biochemistry
|
August 5, 2008
A noncommercial polymerase chain reaction-based method to approach one hundred percent recombinant clone selection efficiency
Mohammed M Shareef, Horatiu C Dancea, Jessica L Gross, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 25, 2016
Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands
Jason R Healy, Padmavani Bezawada, Nicholas W Griggs, et al.
British Journal of Pharmacology
|
January 21, 2018
In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration
Jessica P Anand, Kelsey E Kochan, Anthony F Nastase, et al.
Plos Neglected Tropical Diseases
|
January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model
Erin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.
Journal of Medicinal Chemistry
|
November 3, 2015
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities
Aubrie A Harland, Larisa Yeomans, Nicholas W Griggs, et al.
Bioscience Reports
|
September 25, 2008
Autoactivation of human ADAM8: a novel pre-processing step is required for catalytic activity
Troii Hall, Joseph W Leone, Joseph F Wiese, et al.
The Journal of Clinical Investigation
|
May 1, 1997
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo
V W Engleman, G A Nickols, F P Ross, et al.
Chemical Biology & Drug Design
|
February 24, 2006
Discovery of diphenylmethanepropionic and dihydrostilbeneacetic acids as antagonists of the integrin alphavbeta3
Srinivasan R Nagarajan, Jane M Meyer, Julie M Miyashiro, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
American Journal of Physiology. Cell Physiology
|
May 15, 2023
Combined application of biosponges and an antifibrotic agent for the treatment of volumetric muscle loss
Charles West, Connor Tobo, Jeffrey Au, et al.
Biochemical and Biophysical Research Communications
|
September 23, 2006
VCC-1, a novel chemokine, promotes tumor growth
Edward J Weinstein, Richard Head, David W Griggs, et al.
Analytical Biochemistry
|
August 5, 2008
A noncommercial polymerase chain reaction-based method to approach one hundred percent recombinant clone selection efficiency
Mohammed M Shareef, Horatiu C Dancea, Jessica L Gross, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 25, 2016
Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands
Jason R Healy, Padmavani Bezawada, Nicholas W Griggs, et al.
British Journal of Pharmacology
|
January 21, 2018
In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration
Jessica P Anand, Kelsey E Kochan, Anthony F Nastase, et al.
Plos Neglected Tropical Diseases
|
January 9, 2018
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model
Erin Stebbins, Rajiv S Jumani, Connor Klopfer, et al.
Journal of Medicinal Chemistry
|
November 3, 2015
Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities
Aubrie A Harland, Larisa Yeomans, Nicholas W Griggs, et al.
Bioscience Reports
|
September 25, 2008
Autoactivation of human ADAM8: a novel pre-processing step is required for catalytic activity
Troii Hall, Joseph W Leone, Joseph F Wiese, et al.
The Journal of Clinical Investigation
|
May 1, 1997
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo
V W Engleman, G A Nickols, F P Ross, et al.
Chemical Biology & Drug Design
|
February 24, 2006
Discovery of diphenylmethanepropionic and dihydrostilbeneacetic acids as antagonists of the integrin alphavbeta3
Srinivasan R Nagarajan, Jane M Meyer, Julie M Miyashiro, et al.
Page
of 9